Nature Coast Clinical Research ( Site 1045), Inverness
Research Associates of South Florida - Miami - Southwest 8th Street ( Site 1072), Miami
AdventHealth Orlando ( Site 1074), Orlando

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/09/28更新 · NCT07463183

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Clinical Research of Osceola, LLC, Kissimmee

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/28更新 · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

American Institute of Research, Cutler Bay
Nature Coast Clinical Research, Inverness
Florida Research Institute, Lakewood Rch
他1件

被験者募集中第3相

12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Research Associates of South Florida - Miami - Southwest 8th Street, Miami
Gastro Health Research - Miami, Miami
Orlando Health, Orlando
他3件

被験者募集中第3相

18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Gastro Health Research - Miami, Miami
Ezy Medical Research, Miami Lakes

被験者募集中第2相

18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

NeoClinical Research, Hialeah
Encore Borland-Groover Clinical Research, Jacksonville
Clinical Research of Osceola, Kissimmee
他4件

被験者募集中第2相

18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

K2 Medical Research - Daytona Beach, Daytona Beach
Clinical Research of Osceola, Kissimmee
Florida Research Institute, Lakewood Rch
他1件

被験者募集中第2相

18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Endoscopic Research Inc, Orlando
Alliance Clinical Research of Tampa, LLC, Tampa

被験者募集中第4相

18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT06095128

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Miami Clinical Research, Miami
GCP Clinical Research, Tampa

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/09/21更新 · NCT07513181

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Royal Palm Clinical Research - Site Number: 8400065, Fort Myers
Clinical Research of Osceola - Site Number: 8400013, Kissimmee
Bioresearch Partner-Kendale Lakes - Site Number: 8400053, Miami
他1件

被験者募集中第3相

16歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07185009

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis

Syneos Health Miami, Miami

被験者募集中第1相健康なボランティア歓迎

18歳〜55歳 · 全性別 · 2026/09/09更新 · NCT07749768

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

Florida Research Center Inc., Lakewood Rch
Sanchez Clinical Research, Inc, Miami
GCP Clinical Research, Tampa

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/28更新 · NCT07577856

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Primary Care of Osceola, Kissimmee
Florida Research Institute, Lakewood Rch
University of Miami, Miami
他1件

被験者募集中第2相

18歳〜80歳 · 全性別 · 2026/08/21更新 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Novum Research, LLC - Site Number: 8400003, Clermont
Precision Clinical Research-Site Number: 8400059, Coral Springs
Sarkis Clinical Trials-Ocala - Site Number: 8400048, Gainesville
他12件

被験者募集中第3相

16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Mayo Clinic Jacksonville, Jacksonville
Advent Health, Orlando

被験者募集中

18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

University of Miami, Miami
AdventHealth, Orlando

被験者募集中観察研究

18歳以上 · 全性別 · 2026/08/05更新 · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Digestive and Liver Center of Florida Kissimmee, Kissimmee
Orlando Health/Digestive Health Institute, Orlando

被験者募集中観察研究

18歳〜64歳 · 全性別 · 2026/07/09更新 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Arnold Palmer Hospital - Center for Digestive Health and Nutrition, Orlando

被験者募集中第2相

12歳〜17歳 · 全性別 · 2026/07/08更新 · NCT05287126

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

AP Medical Research LLC, Miami
Edward Jenner Research Group, LLC, Plantation
Adtremed Research Clinic, Tampa

被験者募集中第1相

18歳〜65歳 · 全性別 · 2026/06/12更新 · NCT05666960

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

Med-Care Research Corp, Miami

被験者募集中観察研究健康なボランティア歓迎

22歳以上 · 全性別 · 2026/04/28更新 · NCT06810518

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

Investigational Site Number: 8400024, Jacksonville
Investigational Site Number: 8400030, Kissimmee
Investigational Site Number: 8400003, Lighthouse PT
他4件

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/04/23更新 · NCT06975722

Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC)

University of Miami Health System, Miami

被験者募集中

16歳〜75歳 · 全性別 · 2026/03/30更新 · NCT06784323

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Mirador Therapeutics Selected Site, Miami
Mirador Therapeutics Selected Site, Miami
Mirador Therapeutics Selected Site, Miami
他3件

被験者募集中第2相

18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

University of Miami Health, Miami
Orlando Health, Orlando

被験者募集中

18歳〜85歳 · 全性別 · 2026/01/08更新 · NCT05987852

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。